Welcoming Dr. Mikael Dolsten to the Averin Advisory Board
We are excited to announce that Dr. Mikael Dolsten has joined Averin Capital as an advisor. A physician-scientist and biotechnology leader with more than 35 years at the forefront of biomedical innovation, Mikael brings extraordinary scientific depth and strategic experience to our work at the intersection of life sciences and AI.